Vitamin A responsive night blindness in Dent’s disease

Pediatric Nephrology volume 24, pages1765–1770(2009)Cite this article

Abstract

Dent’s disease is an X-linked renal tubular disorder characterized by low molecular weight proteinuria, hypercalciuria and nephrocalcinosis or nephrolithiasis. The disease is caused by mutations in a renal chloride channel gene, CLCN5. We report on three boys, of Indian origin, with Dent’s disease that presented at an early age (1–4 years), with polyuria, polydipsia, salt craving, recurrent vitamin A-responsive night blindness, hypophosphataemic rickets, hypercalciuria and low molecular weight proteinuria. All these patients were found to have novel mutations in the CLCN5 gene.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. 1.

    Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV (1993) Dent’s disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Mol Genet 2:2129–2134

    CAS  Article  Google Scholar 

  2. 2.

    Wrong OM, Norden AG, Feest TG (1994) Dent’s disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493

    CAS  Google Scholar 

  3. 3.

    Thakker RV (1998) The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis. Curr Opin Nephrol Hypertens 7:385–388

    CAS  Article  Google Scholar 

  4. 4.

    Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325:681–686

    CAS  Article  Google Scholar 

  5. 5.

    Bolino A, Devoto M, Enia G, Zoccali C, Weissenbach J, Romeo G (1993) Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet 1:269–279

    CAS  Article  Google Scholar 

  6. 6.

    Igarashi T, Gunther W, Sekine T, Inatomi J, Shiraga H, Takahashi S, Suzuki J, Tsuru N, Yanagihara T, Shimazu M, Jentsch TJ, Thakker RV (1998) Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent’s Japan disease. Kidney Int 54:1850–1856

    CAS  Article  Google Scholar 

  7. 7.

    Morimoto T, Uchida S, Sakamoto H, Kondo Y, Hanamizu H, Fukui M, Tomino Y, Nagano N, Sasaki S, Marumo F (1998) Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria. J Am Soc Nephrol 9:811–818

    CAS  PubMed  Google Scholar 

  8. 8.

    Lloyd SE, Gunther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ, Thakker RV (1997) Characterization of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 6:1233–1239

    CAS  Article  Google Scholar 

  9. 9.

    Fisher SE, van Bakel I, Lloyd SE, Pearce SH, Thakker RV, Craig IW (1995) Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 29:598–606

    CAS  Article  Google Scholar 

  10. 10.

    Jentsch TJ, Friedrich T, Schriever A, Yamada H (1999) The CLC chloride channel family. Pflugers Arch 437:783–795

    CAS  Article  Google Scholar 

  11. 11.

    Woitas RP, Stoffel-Wagner B, Poege U, Schiedermaier P, Spengler U, Sauerbruch T (2001) Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem 47:2179–2180

    CAS  Article  Google Scholar 

  12. 12.

    Ludwig M, Doroszewicz J, Seyberth HW, Bökenkamp A, Balluch B, Nuutinen M, Utsch B, Waldegger S (2005) Functional evaluation of Dent’s disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Hum Genet 117:228–237

    Article  Google Scholar 

  13. 13.

    Cheong HI, Lee JW, Zheng SH, Lee JH, Kang JH, Kang HG, Ha IS, Lee SJ, Choi Y (2005) Phenotype and genotype of Dent’s disease in three Korean boys. Pediatr Nephrol 20:455–459

    Article  Google Scholar 

  14. 14.

    Tosetto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, Ratsch IM, Citron L, Gambaro G, D’angelo A, Anglani F (2006) Phenotypic and genetic heterogeneity in Dent’s disease—the results of an Italian collaborative study. Nephrol Dial Transplant 21:2452–2463

    CAS  Article  Google Scholar 

  15. 15.

    Hoopes RR Jr, Raja KM, Koich A, Hueber P, Reid R, Knohl SJ, Scheinman SJ (2004) Evidence for genetic heterogeneity in Dent’s disease. Kidney Int 65:1615–1620

    CAS  Article  Google Scholar 

  16. 16.

    WHO global database on vitamin A deficiency (2007) https://doi.org/who.int/vmnis/vitamina/data/database/countries/ind_vita.pdf (updated 6 December 2007; cited 10 February 2009)

  17. 17.

    Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O (2000) Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240–249

    CAS  Article  Google Scholar 

  18. 18.

    Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BHF, Wutz K, Gutwillinger N, Ruether K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A (1998) An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 19:260–263

    CAS  Article  Google Scholar 

  19. 19.

    Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV (1999) Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum Mol Genet 8:247–257

    CAS  Article  Google Scholar 

  20. 20.

    Ghoshal AK, Soldin SJ (2003) Evaluation of the Dade Behring Dimension RxL: integrated chemistry system—pediatric reference ranges. Clin Chim Acta 331:135–146

    CAS  Article  Google Scholar 

Download references

Acknowledgements

Pia Uerdingen is acknowledged for excellent technical assistance.

Author information

Affiliations

  1. Department of Pediatrics, Division of Pediatric Nephrology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Sidharth Kumar Sethi, Pankaj Hari & Arvind Bagga

  2. Department of Clinical Chemistry and Pharmacology, University of Bonn, Bonn, Germany

    Michael Ludwig

  3. Genetics Unit, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India

    Madhulika Kabra

Authors
  1. Sidharth Kumar Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Madhulika Kabra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pankaj Hari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arvind Bagga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arvind Bagga.

Additional information

S.K. Sethi and M. Ludwig contributed equally to the manuscript.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sethi, S.K., Ludwig, M., Kabra, M. et al. Vitamin A responsive night blindness in Dent’s disease. Pediatr Nephrol 24, 1765–1770 (2009). https://doi.org/10.1007/s00467-009-1198-6

Download citation

Keywords

  • CLCN5
  • Hypercalciuria
  • Hypophosphataemic rickets
  • Nyctalopia
  • Night blindness
  • Dent’s disease